Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Ariad Pharma Discontinues Phase III Trial of Ponatinib (Iclusig) in Leukemia Patients

 

Ariad Pharma Discontinues Phase III Trial of Ponatinib (Iclusig) in Leukemia Patients

2013-10-20 13:07:47| Biotech - Topix.net

Ariad Pharmaceuticals, Inc. has announced that it is discontinuing the phase III EPIC trial of ponatinib in patients with newly diagnosed chronic myeloid leukemia .

Tags: iii trial phase patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

05.11 Tropical Storm Rafael Graphics 05.11 Tropical Storm Rafael Forecast Discussion Number 6 05.11 Tropical Storm Rafael Wind Speed Probabilities Number 6 05.11 Tropical Storm Rafael Public Advisory Number 6 05.11 Summary for Tropical Storm Rafael (AT3/AL182024) 05.11 Tropical Storm Rafael Forecast Advisory Number 6 05.11 Why colouring clothes has a big environmental impact 05.11 Atlantic Tropical Weather Outlook More »